The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study
Open accessAbstract
IMPORTANCE: Probiotics have been hypothesized to affect immunologic responses to environmental exposures by supporting healthy gut microbiota and could therefore theoretically be used to prevent the development of type 1 diabetes mellitus (T1DM)-associated islet autoimmunity. OBJECTIVE: To examine the association between supplemental probiotic use during the first year of life and islet autoimmunity among children at increased genetic risk of T1DM. DESIGN, SETTING, AND PARTICIPANTS: In this ongoing prospective cohort study that started September 1, 2004, children from 6 clinical centers, 3 in the United States (Colorado, Georgia/Florida, and Washington) and 3 in Europe (Finland, Germany, and Sweden), were followed up for T1DM-related autoantibodies. Blood samples were collected every 3 months between 3 and 48 months of age and every 6 months thereafter to determine persistent islet autoimmunity. Details of infant feeding, including probiotic supplementation and infant formula use, were monitored from birth using questionnaires and diaries. We applied time-to-event analysis to study the association between probiotic use and islet autoimmunity, stratifying by country and adjusting for family history of type 1 diabetes, HLA-DR-DQ genotypes, sex, birth order, mode of delivery, exclusive breastfeeding, birth year, child's antibiotic use, and diarrheal history, as well as maternal age, probiotic use, and smoking. Altogether 8676 infants with an eligible genotype were enrolled in the follow-up study before the age of 4 months. The final sample consisted of 7473 children with the age range of 4 to 10 years (as of October 31, 2014). EXPOSURES: Early intake of probiotics. MAIN OUTCOMES AND MEASURES: Islet autoimmunity revealed by specific islet autoantibodies. RESULTS: Early probiotic supplementation (at the age of 0-27 days) was associated with a decreased risk of islet autoimmunity when compared with probiotic supplementation after 27 days or no probiotic supplementation (hazard ratio [HR], 0.66; 95% CI, 0.46-0.94). The association was accounted for by children with the DR3/4 genotype (HR, 0.40; 95% CI, 0.21-0.74) and was absent among other genotypes (HR, 0.97; 95% CI, 0.62-1.54). CONCLUSIONS AND RELEVANCE: Early probiotic supplementation may reduce the risk of islet autoimmunity in children at the highest genetic risk of T1DM. The result needs to be confirmed in further studies before any recommendation of probiotics use is made.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 1×
“Infants who have an FDR with T1DM were eligible for enrollment if they had any of the following HLA genotypes: (1) DR4-DQA1*03- DQB1*03:02/DR3-DQA1*05:01-DQB1*02: 01, (2) DR4-DQA1*03- DQB1*03:02/DR4-DQA1*03-DQB1*03: 02, (3) DR4-DQA1*03- DQB1*03:02/DR8-DQA1*04:01-DQB1*04: 02, (4) DR3-DQA1*05:01-DQB1*02:01/DR3-DQA1*05:0…”
The Placenta Harbors a Unique Microbiome
Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., & Versalovic, J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008599 · Cited by 2,494
Factors influencing the composition of the intestinal microbiota in early infancy
Penders, J., Thijs, C., Vink, C., Stelma, F. F., Snijders, B., Kummeling, I., van den Brandt, P. A., & Stobberingh, E. E. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2824 · Cited by 2,232
The role of the gut microbiota in nutrition and health
Flint, H. J., Scott, K. P., Louis, P., & Duncan, S. H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.156 · Cited by 2,182
Reciprocal interactions of the intestinal microbiota and immune system
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012) · Nature · doi:10.1038/nature11551 · Cited by 1,598 · cited 1×
“Infants who have an FDR with T1DM were eligible for enrollment if they had any of the following HLA genotypes: (1) DR4-DQA1*03- DQB1*03:02/DR3-DQA1*05:01-DQB1*02: 01, (2) DR4-DQA1*03- DQB1*03:02/DR4-DQA1*03-DQB1*03: 02, (3) DR4-DQA1*03- DQB1*03:02/DR8-DQA1*04:01-DQB1*04: 02, (4) DR3-DQA1*05:01-DQB1*02:01/DR3-DQA1*05:0…”
Kostic, A. D., Gevers, D., Siljander, H., Vatanen, T., Hyötyläinen, T., Hämäläinen, A.-M., Peet, A., Tillmann, V., Pöhö, P., Mattila, I., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.001 · Cited by 1,186
Self-citationToward defining the autoimmune microbiome for type 1 diabetes
Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Novelo, L. L., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.92 · Cited by 806
Self-citationHuman milk is a source of lactic acid bacteria for the infant gut
Martín, R., Langa, S., Reviriego, C., Jimínez, E., Marín, M. L., Xaus, J., Fernández, L., & Rodríguez, J. M. (2003) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.09.028 · Cited by 792 · cited 1×
“Age at first exposure to probiotics, median (IQR), d 137 (56-244) 28 (14-105) 84 (14-198) 35 (21-70) 42 (14-152)”
Murri, M., Leiva, I., Gomez-Zumaquero, J. M., Tinahones, F. J., Cardona, F., Soriguer, F., & Queipo-Ortuño, M. I. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-46 · Cited by 765
Tlaskalová-Hogenová, H., Štěpánková, R., Kozáková, H., Hudcovic, T., Vannucci, L., Tučková, L., Rossmann, P., Hrnčíř, T., Kverka, M., Zákostelská, Z., et al. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.67 · Cited by 693 · cited 2×
“Infants who have an FDR with T1DM were eligible for enrollment if they had any of the following HLA genotypes: (1) DR4-DQA1*03- DQB1*03:02/DR3-DQA1*05:01-DQB1*02: 01, (2) DR4-DQA1*03- DQB1*03:02/DR4-DQA1*03-DQB1*03: 02, (3) DR4-DQA1*03- DQB1*03:02/DR8-DQA1*04:01-DQB1*04: 02, (4) DR3-DQA1*05:01-DQB1*02:01/DR3-DQA1*05:0…”
Timing of initial cereal exposure in infancy and risk of islet autoimmunity
Norris, J. M. (2003) · JAMA · doi:10.1001/jama.290.13.1713 · Cited by 515
Self-citationThe “Perfect Storm” for Type 1 Diabetes
Vaarala, O., Atkinson, M. A., & Neu, J. (2008) · Diabetes · doi:10.2337/db08-0331 · Cited by 497
Increased intestinal permeability precedes clinical onset of type 1 diabetes
Bosi, E., Molteni, L., Radaelli, M. G., Folini, L., Fermo, I., Bazzigaluppi, E., Piemonti, L., Pastore, M. R., & Paroni, R. (2006) · Diabetologia · doi:10.1007/s00125-006-0465-3 · Cited by 443
Salminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., & Järvinen, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342912 · Cited by 419
Fallani, M., Amarri, S., Uusijarvi, A., Adam, R., Khanna, S., Aguilera, M., Gil, A., Vieites, J. M., Norin, E., Young, D., et al. (2011) · Microbiology · doi:10.1099/mic.0.042143-0 · Cited by 391
Honeyman, M. C., Coulson, B. S., Stone, N. L., Gellert, S. A., Goldwater, P. N., Steele, C. E., Couper, J. J., Tait, B. D., Colman, P. G., & Harrison, L. C. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1319 · Cited by 384
Gut microbiota, probiotics and diabetes
Gomes, A. C., Bueno, A. A., de Souza, R. G. M., & Mota, J. F. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-60 · Cited by 363
The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design
The TEDDY Study Group (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00269.x · Cited by 361
Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato, V., Marzotti, S., Corneli, R. B., Ferretti, E., Gulino, A., Grasso, F., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1831-2 · Cited by 352
The Environmental Determinants of Diabetes in the Young (TEDDY) Study
TEDDY Study Group (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.062 · Cited by 306
Bonifacio, E., Yu, L., Williams, A. K., Eisenbarth, G. S., Bingley, P. J., Marcovina, S. M., Adler, K., Ziegler, A. G., Mueller, P. W., Schatz, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0293 · Cited by 291
Self-citationTörn, C., Mueller, P. W., Schlosser, M., Bonifacio, E., Bingley, P. J., & Laboratories, P. (2008) · Diabetologia · doi:10.1007/s00125-008-0967-2 · Cited by 284
Incidence of Type 1 Diabetes in Finland
Harjutsalo, V., Sund, R., Knip, M., & Groop, P.-H. (2013) · JAMA · doi:10.1001/jama.2013.8399 · Cited by 264
Hagopian, W. A., Erlich, H., Lernmark, Å., Rewers, M., Ziegler, A. G., Simell, O., Akolkar, B., Vogt, R., Blair, A., Ilonen, J., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00774.x · Cited by 260
Self-citationFecal microbiota imbalance in Mexican children with type 1 diabetes
Mejía-León, M. E., Petrosino, J. F., Ajami, N. J., Domínguez-Bello, M. G., & de la Barca, A. M. C. (2014) · Scientific Reports · doi:10.1038/srep03814 · Cited by 235
Nutritional risk predictors of β cell autoimmunity and type 1 diabetes at a young age
Virtanen, S. M., & Knip, M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.6.1053 · Cited by 220 · cited 1×
“Age at first exposure to probiotics, median (IQR), d 137 (56-244) 28 (14-105) 84 (14-198) 35 (21-70) 42 (14-152)”
Self-citationThe changing epidemiology of type 1 diabetes: why is it going through the roof?
Vehik, K., & Dabelea, D. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1141 · Cited by 175
The Role of Microbes in Developmental Immunologic Programming
Kaplan, J. L., Shi, H. N., & Walker, W. A. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318217638a · Cited by 171
Initial Intestinal Colonization in the Human Infant and Immune Homeostasis
Walker, W. A. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000354907 · Cited by 161 · cited 1×
“Age at first exposure to probiotics, median (IQR), d 137 (56-244) 28 (14-105) 84 (14-198) 35 (21-70) 42 (14-152)”
Inhibition of Type 1 Diabetes Correlated to a Lactobacillus johnsonii N6.2-Mediated Th17 Bias
Lau, K., Benitez, P., Ardissone, A., Wilson, T. D., Collins, E. L., Lorca, G., Li, N., Sankar, D., Wasserfall, C., Neu, J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001864 · Cited by 158
Infant feeding and the risk of type 1 diabetes
Knip, M., Virtanen, S. M., & Åkerblom, H. K. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28701c · Cited by 156 · cited 1×
“Age at first exposure to probiotics, median (IQR), d 137 (56-244) 28 (14-105) 84 (14-198) 35 (21-70) 42 (14-152)”
Self-citationProbiotics to Prevent or Treat Excessive Infant Crying: Systematic Review and Meta-analysis
Sung, V., Collett, S., de Gooyer, T., Hiscock, H., Tang, M. L. K., & Wake, M. A. (2013) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.2572 · Cited by 141
Siggers, R. H., Siggers, J., Thymann, T., Boyé, M., & Sangild, P. T. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.08.002 · Cited by 126
Lactobacilli in the intestinal microbiota of Swedish infants
Ahrné, S., Lönnermark, E., Wold, A. E., Åberg, N., Hesselmar, B., Saalman, R., Strannegård, I., Molin, G., & Adlerberth, I. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.04.011 · Cited by 125
Beyerlein, A., Wehweck, F. S., Ziegler, A., & Pflueger, M. (2013) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.158 · Cited by 109
Self-citationThe role of the intestinal microbiota in type 1 diabetes
Hara, N., Alkanani, A. K., Ir, D., Robertson, C. E., Wagner, B. D., Frank, D. N., & Zipris, D. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.12.001 · Cited by 97
Management strategies in the treatment of neonatal and pediatric gastroenteritis
Caramia, G., Ciccarelli, S., & Stolfi, I. (2013) · Infection and Drug Resistance · doi:10.2147/idr.s12718 · Cited by 79
Probiotics in human milk and probiotic supplementation in infant nutrition: a workshop report
Bergmann, H., Rodríguez, J. M., Salminen, S., & Szajewska, H. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001949 · Cited by 79
Use of antimicrobials and risk of type 1 diabetes in a population-based mother–child cohort
Kilkkinen, A., Virtanen, S. M., Klaukka, T., Kenward, M. G., Salkinoja-Salonen, M. S., Gissler, M., Kaila, M., & Reunanen, A. (2005) · Diabetologia · doi:10.1007/s00125-005-0078-2 · Cited by 69
Self-citationMode of delivery directs the phagocyte functions of infants for the first 6 months of life
Grönlund, M., Nuutila, J., Pelto, L., Lilius, E. ‐., Isolauri, E., Salminen, S., Kero, P. O., & Lehtonen, O.-P. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00902.x · Cited by 61
The Human Microbiome and Probiotics: Implications for Pediatrics
Hsieh, M. H., & Versalovic, J. A. (2008) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2008.09.001 · Cited by 53
Senz, M., van Lengerich, B., Bader, J., & Ståhl, U. (2014) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2014.09.015 · Cited by 38
Galleri, L., Sebastiani, G., Vendrame, F., Grieco, F. A., Spagnuolo, I., & Dotta, F. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_20 · Cited by 32
Mäkinen, M., Simell, V., Mykkänen, J., Ilonen, J., Veijola, R., Hyöty, H., Knip, M., Simell, O., Toppari, J., & Hermann, R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1455 · Cited by 32
Self-citationThe TEDDY study group, Lönnrot, M., Lynch, K. F., Larsson, H. E., Lernmark, Å., Rewers, M., Hagopian, W., She, J., Simell, O., Ziegler, A., et al. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0333-8 · Cited by 29
Self-citationComparison of insulin autoantibody: polyethylene glycol and micro‐IAA 1‐day and 7‐day assays
Babaya, N., Yu, L., Miao, D., Wang, J., Rewers, M., Nakayama, M., Liu, E., Barker, J. M., & Eisenbarth, G. S. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1014 · Cited by 23
Self-citationSalami, F., Abels, M., Hyöty, H., Vaziri‐Sani, F., Aronsson, C. A., Vehik, K., Delli, A. J., Hagopian, W., Rewers, M. J., Ziegler, A., et al. (2012) · PubMed · Cited by 6
Self-citation
Cited by
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Current understanding of the human microbiome
Gilbert, J. A., Blaser, M. J., Caporaso, J. G., Jansson, J. K., Lynch, S. V., & Knight, R. (2018) · Nature Medicine · doi:10.1038/nm.4517 · Cited by 2,609
The gut microbiome: Relationships with disease and opportunities for therapy
Durack, J., & Lynch, S. V. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180448 · Cited by 943
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
Vatanen, T., Franzosa, E. A., Schwager, R., Tripathi, S., Arthur, T. D., Vehik, K., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., et al. (2018) · Nature · doi:10.1038/s41586-018-0620-2 · Cited by 886
Self-citation
Metadata
- Authors
- Uusitalo, U., Liu, X., Yang, J., Aronsson, C. A., Hummel, S., Butterworth, M., Lernmark, Å., Rewers, M., Hagopian, W., She, J.-X., Simell, O., Toppari, J., Ziegler, A. G., Akolkar, B., Krischer, J., Norris, J. M., Virtanen, S. M., & for the TEDDY Study Group
- Venue
- JAMA Pediatrics
- Publisher
- American Medical Association (AMA)
- Published
- 2016-01-01
- Volume
- 170
- Issue
- 1
- Pages
- 20
- ISSN
- 1072-4710 (ISSN-L)
- 2168-6203
- OpenAlex
- W2172910482
- Cited by
- 292
- References
- 50
- FWCI
- 16.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.